TRIPS

GENEVA

Q&A: A Healthy Verdict from India

By Gustavo Capdevila
India’s refusal to grant patent protection for the anti-cancer drug Glivec, developed by Swiss drugmaker Novartis, is a victory for the developing world, which depends on low-cost exports of generic medicines from the Asian giant, said public health specialist Germán Velásquez.
MKhor

Will India Still Supply Cheap Drugs to the World?

By Martin Khor
India may be famous for the Taj Mahal, its religious ceremonies, Bollywood films and one of the highest economic growth rates in recent years. But more importantly, India has had a positive global impact through its supply of vast quantities of low-cost, good-quality generic medicines, which have saved or prolonged millions of lives.

Protesters: Free Trade Deals, Drug Patents Derail AIDS Fight

By Amanda Wilson
As the nineteenth International AIDS Conference continued in Washington Tuesday, thousands of protesters marched on the White House with a set of demands to end the epidemic.